Career history of Hans-Ulrich Demuth
Former positions of Hans-Ulrich Demuth
| Companies | Position | Start | End |
|---|---|---|---|
| VIVORYON THERAPEUTICS N.V. | Chief Tech/Sci/R&D Officer | 30/11/1997 | 30/01/2013 |
| Founder | 24/07/1997 | 30/01/2013 | |
| Hochschule Anhalt | Corporate Officer/Principal | - | - |
Ingenium Pharmaceuticals GmbH
 Ingenium Pharmaceuticals GmbH Miscellaneous Commercial ServicesCommercial Services Ingenium Pharmaceuticals GmbH operates as a biopharmaceutical company specializing in the development of small molecule drugs. They develop inhibitors and ligands targeting key enzymes such as proteases and kinases. Their therapeutic compounds are used for the treatment of memory-related and chronic inflammatory disorders. Their focus areas cover human therapeutics, vivo pharmacology, and disease pathology. The company was founded in 1998 and is headquartered in Munich, Germany. | Chief Executive Officer | 03/11/2009 | - |
| Martin-Luther-Universität Halle-Wittenberg | Corporate Officer/Principal | - | - |
Training of Hans-Ulrich Demuth
| Martin-Luther-Universität Halle-Wittenberg | Undergraduate Degree |
Statistics
International
| Germany | 4 |
| 2 |
Operational
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Founder | 1 |
Sectoral
| Consumer Services | 3 |
| Health Technology | 2 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| VIVORYON THERAPEUTICS N.V. | Health Technology |
| Private companies | 1 |
|---|---|
Ingenium Pharmaceuticals GmbH
Ingenium Pharmaceuticals GmbH Miscellaneous Commercial ServicesCommercial Services Ingenium Pharmaceuticals GmbH operates as a biopharmaceutical company specializing in the development of small molecule drugs. They develop inhibitors and ligands targeting key enzymes such as proteases and kinases. Their therapeutic compounds are used for the treatment of memory-related and chronic inflammatory disorders. Their focus areas cover human therapeutics, vivo pharmacology, and disease pathology. The company was founded in 1998 and is headquartered in Munich, Germany. | Commercial Services |
- Stock Market
- Insiders
- Hans-Ulrich Demuth
- Experience
